Infection
Infectious Disease·MeSH: Cross Infection
Prevalence
380.0 / 100K
Incidence
12.0 / 100K/yr
437 drugs in development·135 companies·5 clinical trials
Drug Pipeline by Phase
Approved(91)
Phase 3(78)
Phase 2(81)
Phase 1(96)
Preclinical(33)
Unknown(11)
BLA Filed(3)
Early Phase 1(1)
| Drug | Company |
|---|---|
| VTP-400 | Barinthus Biotherapeutics plc. (BRNS) |
N/A(1)
Phase 1/Phase 2(9)
Phase 2/Phase 3(5)
Phase 4(28)
Compare drugs
Frequently asked questions
How many drugs are in development for Infection?
BioSniper tracks 437 drugs in development for Infection across 135 companies.
How many clinical trials target Infection?
There are 5 clinical trials targeting Infection tracked by BioSniper.
What is the prevalence of Infection?
The estimated prevalence of Infection is approximately 380.0 per 100,000 population.
Deep-dive into Infection
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis